Results 251 to 260 of about 1,000,812 (307)

Alternative indications for corneal crosslinking

Journal of Cataract & Refractive Surgery, 2021
Corneal crosslinking (CXL) is the current mainstay treatment for progressive keratoconus. In the past 15 years, a variety of other indications have been tested. A systematic review was conducted to examine these alternative indications for CXL. In total, 143 papers on crosslinking as a treatment for infectious keratitis, bullous keratopathy, pellucid ...
Laurens, Van Tigchelt, Jan, Van Eijgen, Heleen, Delbeke   +2 more
openaire   +2 more sources

Alternative Clinical Indications of Botulinum Toxin

American Journal of Clinical Dermatology, 2020
Botulinum toxin type A (BoNTA) is a powerful neurotoxin that inhibits acetylcholine release from presynaptic vesicles. The potency and safety profile of BoNTA grant the toxin vast therapeutic potential. It has been used off-label for a variety of dermatologic conditions.
Tina S. Alster, Iris S. Harrison
openaire   +2 more sources

Indications and Alternatives to Hysterectomy

Clinical Obstetrics & Gynecology, 2014
Hysterectomy remains one the most common procedures performed in North America. Because of a better understanding of a wide array of disease states and with emerging, more focused minimally invasive treatment options, a relative decline has been documented in the last several years.
M Jonathan, Solnik, Malcolm G, Munro
openaire   +2 more sources

Alternative anthropometric indicators of mortality

The American Journal of Clinical Nutrition, 1985
The ability of anthropometric indicators, weight-for-age, height-for-age, weight-for-height, weight velocity, and height velocity to discriminate mortality during a one-year period is examined for three time frames beginning in different seasons. Data on approximately 1,000 children of one to four years of age come from the Matlab, International Centre
R, Bairagi, M K, Chowdhury, Y J, Kim, G T, Curlin   +3 more
openaire   +2 more sources

Alternative Indications for Bisphosphonate Therapy

Journal of Oral and Maxillofacial Surgery, 2009
Bisphosphonates are currently used in the treatment of osteoporosis (postmenopausal and steroid-induced), hypercalcemia of malignancy, Paget's disease of bone, multiple myeloma, and skeletally related events associated with metastatic bone disease in breast, prostate, lung, and other cancers.
Regina, Landesberg, Sidney, Eisig, Ilene, Fennoy, Ethel, Siris   +3 more
openaire   +2 more sources